Terms: = Brain cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Clinical Outcome
11 results:
1. The Role of Activation of PI3K/AKT/mtor and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas-New Potential Therapeutic Approach-A Systematic Review.
Derwich A; Sykutera M; Bromińska B; Rubiś B; Ruchała M; Sawicka-Gutaj N
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446128
[TBL] [Abstract] [Full Text] [Related]
2. A concise review on the role of BDNF-AS in human disorders.
Ghafouri-Fard S; Khoshbakht T; Taheri M; Ghanbari M
Biomed Pharmacother; 2021 Oct; 142():112051. PubMed ID: 34426254
[TBL] [Abstract] [Full Text] [Related]
3. Interaction of Discoidin Domain Receptor 1 with a 14-3-3-Beclin-1-Akt1 Complex Modulates Glioblastoma Therapy Sensitivity.
Vehlow A; Klapproth E; Jin S; Hannen R; Hauswald M; Bartsch JW; Nimsky C; Temme A; Leitinger B; Cordes N
Cell Rep; 2019 Mar; 26(13):3672-3683.e7. PubMed ID: 30917320
[TBL] [Abstract] [Full Text] [Related]
4. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract] [Full Text] [Related]
5. AKT/GSK3β Signaling in Glioblastoma.
Majewska E; Szeliga M
Neurochem Res; 2017 Mar; 42(3):918-924. PubMed ID: 27568206
[TBL] [Abstract] [Full Text] [Related]
6. Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis.
Zhou J; Xu T; Qin R; Yan Y; Chen C; Chen Y; Yu H; Xia C; Lu Y; Ding X; Wang Y; Cai X; Chen J
J Neurooncol; 2012 Nov; 110(2):195-203. PubMed ID: 22972189
[TBL] [Abstract] [Full Text] [Related]
7. PTEN promoter methylation and activation of the PI3K/Akt/mtor pathway in pediatric gliomas and influence on clinical outcome.
Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA
Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine.
Metro G; Foglietta J; Russillo M; Stocchi L; Vidiri A; Giannarelli D; Crinò L; Papaldo P; Mottolese M; Cognetti F; Fabi A; Gori S
Ann Oncol; 2011 Mar; 22(3):625-630. PubMed ID: 20724575
[TBL] [Abstract] [Full Text] [Related]
9. Histopathologic predictors of pilocytic astrocytoma event-free survival.
Tibbetts KM; Emnett RJ; Gao F; Perry A; Gutmann DH; Leonard JR
Acta Neuropathol; 2009 Jun; 117(6):657-65. PubMed ID: 19271226
[TBL] [Abstract] [Full Text] [Related]
10. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
[TBL] [Abstract] [Full Text] [Related]
11. brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.
Nakamura K; Martin KC; Jackson JK; Beppu K; Woo CW; Thiele CJ
Cancer Res; 2006 Apr; 66(8):4249-55. PubMed ID: 16618748
[TBL] [Abstract] [Full Text] [Related]